{"filing":{"accession_number":"0001493152-26-042466","cik":"0001535955","ticker":"LPCN","company_name":"Lipocine Inc.","form":"8-K","filing_date":"2026-09-14","report_date":"2026-09-14","primary_document":"form8-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1535955/000149315226042466/form8-k.htm"},"events":[{"id":33074,"run_id":30400,"accession_number":"0001493152-26-042466","anchor_item_number":null,"event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.75,"summary":"Lipocine announced initiation of the BLOOM Phase 3 clinical trial for LPCN 1154 in postpartum depression treatment. This is a material operational and clinical development milestone for a biopharmaceutical company, representing advancement toward potential regulatory submission and commercialization. The disclosure includes study design, enrollment targets, timing, and cash requirements, all of which would affect investor assessment of the company's pipeline progress and capital allocation.","company_name":"Lipocine Inc.","ticker":"LPCN","filing_date":"2026-09-14","form":"8-K","submitted_at":null,"items":null}],"classifications":[{"id":36412,"accession_number":"0001493152-26-042466","item_number":null,"item_title":null,"event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.75,"reasoning":"Lipocine announced initiation of the BLOOM Phase 3 clinical trial for LPCN 1154 in postpartum depression treatment. This is a material operational and clinical development milestone for a biopharmaceutical company, representing advancement toward potential regulatory submission and commercialization. The disclosure includes study design, enrollment targets, timing, and cash requirements, all of which would affect investor assessment of the company's pipeline progress and capital allocation.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-14T10:16:45.872160+00:00","company_name":"Lipocine Inc.","ticker":"LPCN","filing_date":"2026-09-14"}]}